HIV campaigners fear appeal will delay introduction of new treatment

A 'game changing' preventative drug aimed at reducing the high risk of contracting HIV in gay males can be funded by the NHS, the High Court has ruled.

NHS England had stood firm on not commissioning pre-exposure prophylaxis (PrEP) claiming it had 'no legal power' to do so and that the responsibility of preventative health lay with the local authorities - a position challenged by the National Aids Trust (NAT).

In his judgment, however, Mr Justice Green said NHS England had 'erred' in the dereliction of its power or duty to commission PrEP. The NHS has chosen to appeal the decision.

Deborah Gold, NAT chief executive, welcomed the ...

Jean Yves


This article is part of a subscription-based access, to continue reading, please contact your library